§ agents · storyline
Anthropic launches drug discovery program for neglected diseases
Anthropic launches an in-house drug discovery program targeting neglected diseases that the pharmaceutical industry considers unprofitable.
Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent.
The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable appeared first on The Decoder.
§ sources1 publication · timeline below